Drawing for PAXORLEA CARECONNECT

USPTO serial 90398814

PAXORLEA CARECONNECT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
JENKINS JR, CHARLES L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PAXORLEA CARECONNECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anne F. Downey

Anne F. Downey HARTER SECREST & EMERY LLP50 FOUNTAIN PLAZA, SUITE 1000BUFFALO, NY 14202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
041Education services, namely, online and telephone coaching regarding the treatment of cancer; providing education in the form of classes, workshops, seminars, webinars, conferences, and training in the field of pharmaceutical preparations for cancer treatmentACTIVE—
044Providing medical information about cancer and the treatment thereof; providing medical information on pharmaceuticals for the treatment of cancer; medication therapy management, namely, providing information to patients by certified health care professionals in the field of administering medications; providing medical information and online information on the subjects of pharmaceutical preparations; providing medical information and online medical and healthcare information to healthcare professionals and patients on the subject of the treatment of cancer; providing telephone support services to physicians and patients regarding the safe and appropriate use and distribution of medications used to treat cancer; providing medical information via telephone and in the form of written educational materials to physicians and patients in connection with the safe and appropriate use and distribution of medication for the treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 1, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 1, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 2, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 31, 2022EX2GSOU EXTENSION 2 GRANTED—
May 31, 2022EXT2SOU EXTENSION 2 FILED—
May 31, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 4, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 2, 2022EX1GSOU EXTENSION 1 GRANTED—
Mar 2, 2022EXT1SOU EXTENSION 1 FILED—
Mar 2, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 28, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 3, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 3, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 14, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 28, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 16, 2021DOCKASSIGNED TO EXAMINER—
Mar 5, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 24, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance